Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 09 1997, 2288-2292, Vol 35, No. 9
V Dubois, H Dutronc, ME Lafon, V Poinsot, JL Pellegrin, JM Ragnaud, AM Ferrer and HJ Fleury
JC virus (JCV) acts as an opportunistic virus in immunocompromised human
immunodeficiency virus type 1 (HIV-1)-infected patients. The role of
peripheral blood cells in central nervous system invasion, before the onset
of progressive multifocal leukoencephalopathy (PML), remains controversial.
In order to clarify JCV latency or reactivation status in peripheral blood,
72 HIV-1-infected patients were studied, together with 7 HIV-1-positive PML
patients and 50 blood donors. Blood leukocytes, plasma, and B lymphocytes
were investigated by two complementary DNA amplification procedures within
the early T and late VP1 JCV genes and two reverse transcription techniques
for the detection of corresponding early transcripts and mRNAs. JCV DNA was
detected in 40.3% of the HIV-1-infected patients but only 8% of the blood
donors (P < 0.001). Leukocytes represented 82.7% of the positive
samples, but plasma from 12 patients (41.4%) contained JCV DNA. B
lymphocytes seemed to be involved in the natural history of JCV but did not
represent the unique cell target. JCV DNA was intermittently found in
blood, and JCV mRNAs for VP1 capsid protein were detected exclusively in
one PML patient. Such observations demonstrate that JCV, when detected in
blood, does not undergo active multiplication. They support the JCV
hematogenous spread hypothesis, but do not indicate any direct link between
peripheral virus and dissemination in the central nervous system at the
time of immunodepression.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients
Laboratoire de Virologie, Institut Federatif de Recherches en Pathologies Infectieuses, Universite Bordeaux 2, France.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|